3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide

C43H71N11O6 — CID 168851435

IUPAC3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide
SMILESCN1CCN([C@@H]2CCCN(CCNC(C(N)=O)C(N)NC3CCC(C4CCN(CC5CC(NC6CCCC7C(=O)N([C@@H]8CCC(=O)NC8=O)C(=O)C67)C5)CC4)CC3)C2)C1=O
InChIInChI=1S/C43H71N11O6/c1-50-20-21-53(43(50)60)31-4-3-16-51(25-31)19-15-46-37(39(45)56)38(44)48-29-9-7-27(8-10-29)28-13-17-52(18-14-28)24-26-22-30(23-26)47-33-6-2-5-32-36(33)42(59)54(41(32)58)34-11-12-35(55)49-40(34)57/h26-34,36-38,46-48H,2-25,44H2,1H3,(H2,45,56)(H,49,55,57)/t26?,27?,29?,30?,31-,32?,33?,34-,36?,37?,38?/m1/s1
InChIKeyDGHJXTKDKRLNKM-XXZOXURQSA-N
MW838.11 g/mol
LogP-0.27
Rot. Bonds15

About 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide

3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide (PubChem CID 168851435) has the molecular formula C43H71N11O6 and a molecular weight of 838.11 g/mol. Its IUPAC name is 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide.

Molecular Properties

Compound Name3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide
PubChem CID168851435
Molecular FormulaC43H71N11O6
Molecular Weight838.11 g/mol
Exact Mass837.56
IUPAC Name3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide
SMILESCN1CCN([C@@H]2CCCN(CCNC(C(N)=O)C(N)NC3CCC(C4CCN(CC5CC(NC6CCCC7C(=O)N([C@@H]8CCC(=O)NC8=O)C(=O)C67)C5)CC4)CC3)C2)C1=O
InChIInChI=1S/C43H71N11O6/c1-50-20-21-53(43(50)60)31-4-3-16-51(25-31)19-15-46-37(39(45)56)38(44)48-29-9-7-27(8-10-29)28-13-17-52(18-14-28)24-26-22-30(23-26)47-33-6-2-5-32-36(33)42(59)54(41(32)58)34-11-12-35(55)49-40(34)57/h26-34,36-38,46-48H,2-25,44H2,1H3,(H2,45,56)(H,49,55,57)/t26?,27?,29?,30?,31-,32?,33?,34-,36?,37?,38?/m1/s1
InChIKeyDGHJXTKDKRLNKM-XXZOXURQSA-N
XLogP-0.27
TPSA218.78 Ų
H-Bond Donors6
H-Bond Acceptors12
Rotatable Bonds15
Heavy Atoms60
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500838.11
LogP ≤ 5-0.27
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide?
The IUPAC name of 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide (CID 168851435) is 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide.
What is the SMILES notation for 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide?
The canonical SMILES for 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide is CN1CCN([C@@H]2CCCN(CCNC(C(N)=O)C(N)NC3CCC(C4CCN(CC5CC(NC6CCCC7C(=O)N([C@@H]8CCC(=O)NC8=O)C(=O)C67)C5)CC4)CC3)C2)C1=O.
What is the InChIKey of 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide?
The InChIKey is DGHJXTKDKRLNKM-XXZOXURQSA-N. The full InChI is InChI=1S/C43H71N11O6/c1-50-20-21-53(43(50)60)31-4-3-16-51(25-31)19-15-46-37(39(45)56)38(44)48-29-9-7-27(8-10-29)28-13-17-52(18-14-28)24-26-22-30(23-26)47-33-6-2-5-32-36(33)42(59)54(41(32)58)34-11-12-35(55)49-40(34)57/h26-34,36-38,46-48H,2-25,44H2,1H3,(H2,45,56)(H,49,55,57)/t26?,27?,29?,30?,31-,32?,33?,34-,36?,37?,38?/m1/s1.
What are the key properties of 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide?
3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide has a molecular weight of 838.11 g/mol, XLogP of -0.27, 15 rotatable bonds, 6 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-3-[[4-[1-[[3-[[2-[(3R)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]cyclobutyl]methyl]piperidin-4-yl]cyclohexyl]amino]-2-[2-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]ethylamino]propanamide is sourced from PubChem (CID 168851435), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).